Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for Parkinson's disease prevention or treatment

Details for Australian Patent Application No. 2008225318 (hide)

Owner Green Cross Corporation

Inventors Kim, Jeongmin; Lee, Jinhwa; Lee, Suk Ho; Kim, Jong Yup; Lee, MinWoo; Song, Kwang-Seop; Son, Eun Jung; Kim, Min Ju; Han, Ho Kyun; Jung, Myung Eun

Agent Cullens

Pub. Number AU-B-2008225318

PCT Pub. Number WO2008/111767

Priority 60/893,930 09.03.07 US

Filing date 7 March 2008

Wipo publication date 18 September 2008

Acceptance publication date 2 December 2010

International Classifications

C07D 221/28 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/111767 Priority application(s): WO2008/111767

2 December 2010 Application Accepted

  Published as AU-B-2008225318

31 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008225321-A method and an apparatus for processing an audio signal

2008225267-Device for treating and purifying a liquid product